• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,872.69 -1,504.43
(-2.82%)
Dow Jones
7,442.16 -267.46
(-3.47%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.59 -0.14
(-0.15%)
EUR-INR
106.30 0.31
(0.29%)
GBP-INR
127.42 0.36
(0.28%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
200.4589991
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FREDUN
57.55
2557.69
EPS(TTM)
Face Value()
Div & Yield %
25.95
10
0.01
 

Square Four Projects India reports consolidated net loss of Rs 0.10 crore in the March 2026 quarter
May 28,2026
Net Loss of Square Four Projects India reported to Rs 0.10 crore in the quarter ended March 2026 as against net loss of Rs 0.07 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.28 crore in the year ended March 2026 as against net loss of Rs 0.08 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.